Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 2
1970 1
1971 2
1972 3
1973 3
1974 5
1975 4
1976 4
1977 3
1978 1
1980 2
1981 2
1982 3
1983 3
1984 4
1985 5
1986 10
1987 13
1988 7
1989 7
1990 5
1991 11
1992 13
1993 11
1994 11
1995 11
1996 11
1997 15
1998 7
1999 13
2000 9
2001 7
2002 12
2003 9
2004 15
2005 14
2006 10
2007 7
2008 8
2009 4
2010 8
2011 5
2012 6
2013 5
2014 13
2015 8
2016 8
2017 8
2018 7
2019 19
2020 21
2021 17
2022 13
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

419 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO; THOR Cohort 1 Investigators. Loriot Y, et al. N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870920 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
AUTHOR REPLY.
Kubota M, Matsuoka T, Hagimoto H, Yamasaki T, Kawakita M. Kubota M, et al. Among authors: kawakita m. Urology. 2021 Feb;148:158. doi: 10.1016/j.urology.2020.08.097. Urology. 2021. PMID: 33549209 No abstract available.
[A Case of Retroperitoneal Lymphangioleiomyomatosis].
Kambe T, Yamasaki T, Nagoshi A, Fujiwara T, Mine Y, Hagimoto H, Hattori Y, Abe Y, Yamashita D, Tsutsumi N, Kawakita M. Kambe T, et al. Among authors: kawakita m. Hinyokika Kiyo. 2023 Jun;69(6):151-155. doi: 10.14989/ActaUrolJap_69_6_151. Hinyokika Kiyo. 2023. PMID: 37460278 Japanese.
[Nucleotide-sugar transporters].
Ishida N, Kawakita M. Ishida N, et al. Among authors: kawakita m. Tanpakushitsu Kakusan Koso. 2003 Jun;48(8 Suppl):1041-8. Tanpakushitsu Kakusan Koso. 2003. PMID: 12807007 Review. Japanese. No abstract available.
419 results